GRACEcast
Expert oncologists provide brief, distilled summaries of the most central issues in cancer management and emerging approaches for patients and caregivers. The Global Resource for Advancing Cancer Education (GRACE) is committed to providing the knowledge that will help enable the general public to be informed participants in their own care. Visit cancerGRACE.org for more info.

Dr. David Spigel, Sarah Cannon Cancer Center, describes which molecular markers he seeks for NSCLC patients.


Dr. Jared Weiss from the University of North Carolina, Chapel Hill reviews results from HPV-positive patients with head and neck cancer (HNSCC) from recent trials and describes emerging research in this population.

Direct download: GRACEcast-158_HeadNeck-Video_HPV_HNSCC_Clinical_Trials.m4v
Category:Head-Neck-Video -- posted at: 1:41pm PDT

Dr. Jared Weiss from the University of North Carolina, Chapel Hill reviews results from HPV-positive patients with head and neck cancer (HNSCC) from recent trials and describes emerging research in this population.

Direct download: GRACEcast-158_HeadNeck-Audio_HPV_HNSCC_Clinical_Trials.mp3
Category:Head-Neck-Audio -- posted at: 1:41pm PDT

Dr. Jared Weiss from the University of North Carolina, Chapel Hill introduces us to the human papilloma virus and its role as a cause and relevant prognostic factor for head and neck cancer (HNSCC).

Direct download: GRACEcast-157_HeadNeck-Video_HPV_Introduction_HNSCC_Weiss.m4v
Category:Head-Neck-Video -- posted at: 1:40pm PDT

GRACE, cancerGRACE, GRACEcast, Jared Weiss, Unveristy of North Carolina-Chapel Hill, UNC-Chapel Hill, induction therapy, neoadjuvant therapy, head and neck cancer, HNSCC, carbplatin, paclitaxel, cetuximab, Taxol, Erbitux, weekly

Direct download: GRACEcast-157_HeadNeck-Audio_HPV_Introduction_HNSCC_Weiss.mp3
Category:Head-Neck-Audio -- posted at: 1:40pm PDT

Dr. Jared Weiss from the University of North Carolina, reviews several options as induction therapy for head and neck cancer and focuses on the potential appeal and tolerability of the combination of weekly carboplatin and paclitaxel with cetuximab.

Direct download: GRACEcast-156_HeadNeck-Video_Induction_Chemo_HNSCC_Weiss_2.m4v
Category:Head-Neck-Video -- posted at: 10:42am PDT

Dr. Jared Weiss from the University of North Carolina, reviews several options as induction therapy for head and neck cancer and focuses on the potential appeal and tolerability of the combination of weekly carboplatin and paclitaxel with cetuximab.

Direct download: GRACEcast-156_HeadNeck-Audio_Induction_Chemo_HNSCC_Weiss_2.mp3
Category:Head-Neck-Audio -- posted at: 10:42am PDT

Dr. Jared Weiss from the University of North Carolina, Chapel Hill reviews the rationale for induction chemotherapy before surgery for head and neck cancer and highlights the early work that led to the emergence of the TPF regimen in this setting.

Direct download: GRACEcast-155_HeadNeck-Video_Induction_Chemo_HNSCC_Weiss_1.m4v
Category:Head-Neck-Video -- posted at: 2:06pm PDT

Dr. Jared Weiss from the University of North Carolina, Chapel Hill reviews the rationale for induction chemotherapy before surgery for head and neck cancer and highlights the early work that led to the emergence of the TPF regimen in this setting.

Direct download: GRACEcast-155_HeadNeck-Audio_Induction_Chemo_HNSCC_Weiss_1.mp3
Category:Head-Neck-Audio -- posted at: 2:05pm PDT

Dr. Ravi Salgia, from the University of Chicago, describes which patients with advanced non-small cell lung cancer he would recommend getting a repeat biopsy to obtain sufficient tissue to perform molecular marker testing.